Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
Maryanne M. Senna, Arash Mostaghimi, Manabu Ohyama, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 3, pp. 583-593
Open Access | Times Cited: 13

Showing 13 citing articles:

Baricitinib-Induced Remission of Alopecia Universalis in a Child with NFKB2-Associated Immune Dysregulation
Charlotte Blokhuis, Timothy Ronan Leahy, A.D. Irvine, et al.
Journal of Clinical Immunology (2025) Vol. 45, Iss. 1
Closed Access
Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
Moyuka Wada‐Irimada, Takehiro Takahashi, Mana Sekine, et al.
The Journal of Dermatology (2025)
Closed Access
Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
Jair Alejandro Valdez-Zertuche, Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
Chao‐Chun Yang, Chih‐Chiang Chen, Tzu-Kai Lin, et al.
Dermatologica Sinica (2025)
Open Access
Interleukin-15 is a hair follicle immune privilege guardian
Takahiro Suzuki, Jérémy Chéret, FERNANDA DINELLI SCALA, et al.
Journal of Autoimmunity (2024) Vol. 145, pp. 103217-103217
Closed Access | Times Cited: 2
Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
Ruixuan Guan, Yiling Lin, Cun Zhang, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access | Times Cited: 1
A new era for alopecia areata: New treatments and improved knowledge of the condition
Bianca Maria Piraccini
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 3, pp. 458-459
Open Access | Times Cited: 1
Newer Treatments, Treatment Selection, Pipeline Therapies, and Personalized Medicine in Atopic Dermatitis: Where Are We Now?
J.Q. Del Rosso
Clinical Cases in Dermatology (2024), pp. 183-196
Closed Access
Alopecia areata: Baricitinib mit langfristiger Wirkung
Nicola Zink
Deleted Journal (2024) Vol. 72, Iss. 4, pp. 306-307
Closed Access
Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
Brittany G. Craiglow, Yang Won Lee, Sérgio Vañó-Galván, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1959-1968
Open Access
Presenting JAK inhibitor safety information to dermatology patients
A. Teixeira, Jessica Q. Duong, Shirley P. Parraga, et al.
JEADV Clinical Practice (2024)
Open Access
II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
Paulo Müller Ramos, Alessandra Anzai, Bruna Duque‐Estrada, et al.
Anais Brasileiros de Dermatologia (2024)
Open Access
Autoinmune Alopecia/Alopecia Areata
Andrea Combalía
(2024), pp. 505-508
Closed Access
Page 1

Scroll to top